Nasacort and Tracleer drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nasacort (triamcinolone acetonide) and Tracleer (bosentan). Common drug interactions include weight decreased among females and dysphagia among males.

The phase IV clinical study analyzes what interactions people have when they take Nasacort and Tracleer. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Nasacort?

Nasacort has active ingredients of triamcinolone acetonide. It is often used in allergies. eHealthMe is studying from 13,298 Nasacort users. Check the latest studies of Nasacort.

What is Tracleer?

Tracleer has active ingredients of bosentan. It is often used in primary pulmonary hypertension. eHealthMe is studying from 55,125 Tracleer users. Check the latest studies of Tracleer.

On Jul, 16, 2026

26 people who take Nasacort and Tracleer together, and have interactions are studied.

Nasacort and Tracleer drug interactions.

What are the common drug interactions of Nasacort and Tracleer, by gender? *:

female:

Weight decreased
Autoimmune hepatitis
Dyspnoea (difficult or laboured respiration)
Diarrhoea
Pruritus (severe itching of the skin)
Anxiety
Dizziness
Fall
Laceration (tearing of soft body tissue)
Asthenia (weakness)

male:

Dysphagia (a condition in which swallowing is difficult or painful)
Dyspnoea (difficult or laboured respiration)
Diastolic dysfunction
Fatigue (feeling of tiredness)
Presyncope
Pulmonary hypertension (increase in blood pressure in the lung artery)
Right ventricular systolic pressure decreased
Syncope (loss of consciousness with an inability to maintain postural tone)
Tricuspid valve incompetence (inefficient heart valve)
Eye oedema (swelling or thickening of the macula, the area of the retina responsible for central vision)

What are the common drug interactions of Nasacort and Tracleer, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Immobile (not moving)
Infusion site pain
Diarrhoea
Flushing (the warm, red condition of human skin)

10-19:

Pulmonary hypertension (increase in blood pressure in the lung artery)
Right ventricular systolic pressure decreased
Syncope (loss of consciousness with an inability to maintain postural tone)
Tricuspid valve incompetence (inefficient heart valve)
Petechiae (a small red or purple spot caused by bleeding into the skin)
Purpura (purplish discoloration of the skin)
Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
Cardiac disorder
Cardiac hypertrophy (thickening of the heart muscle)
Diastolic dysfunction

20-29:

n/a

30-39:

n/a

40-49:

Cough
Stomatitis (inflammation of mucous membrane of mouth)

50-59:

Autoimmune hepatitis
Drug ineffective
Headache (pain in head)
Respiratory failure (inadequate gas exchange by the respiratory system)
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Anxiety
Cerebral haemorrhage (bleeding within the brain)
Chest pain
Contusion (a type of hematoma of tissue in which capillaries)
Death

60+:

Dyspnoea (difficult or laboured respiration)
Oedema peripheral (superficial swelling)
Rash
Vomiting
Abdominal pain
Abscess limb (limb infection)
Anxiety
Aspartate aminotransferase increased
Blood alkaline phosphatase increased
Blood bilirubin increased

What are the existing conditions these people have? *

Pulmonary Hypertension (increase in blood pressure in the lung artery): 12 people, 46.15%
Pulmonary Hypertension Secondary (increase in blood pressure in the lung artery): 3 people, 11.54%
Insomnia (sleeplessness): 2 people, 7.69%
Discomfort: 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Nasacort and Tracleer?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously